Landscape of Statin as a Cornerstone in Atherosclerotic Cardiovascular Disease

被引:3
|
作者
Yang, Cheng [1 ]
Wu, Yong-Jian [1 ]
Qian, Jie [1 ]
Li, Jian-Jun [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100037, Peoples R China
关键词
statins; cardiovascular disease; lipid-lowering; cornerstone; CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN-CHOLESTEROL; ACUTE MYOCARDIAL-INFARCTION; LOWERING LDL CHOLESTEROL; RANDOMIZED CONTROLLED-TRIALS; CONSENSUS DECISION PATHWAY; CHRONIC KIDNEY-DISEASE; HIGH-DOSE ATORVASTATIN; PRIMARY PREVENTION; ISCHEMIC-STROKE;
D O I
10.31083/j.rcm2412373
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atherosclerosis, the key pathogenesis of cardiovascular disease, is a leading cause of death and disability worldwide. Statins are first-line lipid-lowering drugs, which have been demonstrated to be powerful agents for anti-atherosclerosis. Numerous studies have confirmed the cardiovascular benefits and long-term safety of statins in a wide range of patients. Statins play an indispensable and irreplaceable part in the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD). In this article, we summarize the evolution of statins and their role in the treatment of cholesterol. The anti-atherosclerotic mechanism of statins, its efficacy, safety and clinical outcomes in secondary and primary prevention of ACSVD in different patient populations, the combination treatment effects, and guideline recommendations are also detailed. This paper highlights the profound significance of statins as the most successful anti-atherogenic drug in the cardiovascular field.
引用
收藏
页数:22
相关论文
共 50 条
  • [1] Atherosclerotic cardiovascular disease landscape in Singapore
    Sia, Ching-Hui
    Simon, Oliver
    Loh, Poay-Huan
    Poh, Kian Keong
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [2] Diabetes associated residual atherosclerotic cardiovascular risk in statin-treated patients with prior atherosclerotic cardiovascular disease
    Zhao, Yanglu
    Xiang, Pin
    Coll, Blai
    Lopez, J. Antonio G.
    Wong, Nathan D.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (03)
  • [3] Efficacy and safety of statin treatment for cardiovascular disease
    Zhang XiaoYan
    Guan Qingmin
    Liu Yantao
    Wang Zhijuan
    Xu Meihua
    ETHIOPIAN JOURNAL OF HEALTH DEVELOPMENT, 2021, 35 (04)
  • [4] Statin therapy for the primary prevention of cardiovascular disease: Cons
    Durai, Vivek
    Redberg, Rita F.
    ATHEROSCLEROSIS, 2022, 356 : 46 - 49
  • [5] Statin Use in Older Adults with Stable Atherosclerotic Cardiovascular Disease
    Spencer-Bonilla, Gabriela
    Chung, Sukyung
    Sarraju, Ashish
    Heidenreich, Paul
    Palaniappan, Latha
    Rodriguez, Fatima
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2021, 69 (04) : 979 - 985
  • [6] Smoking and atherosclerotic cardiovascular disease: Part I: Atherosclerotic disease process
    Winkelmann, Bernhard R.
    von Holt, Klaus
    Unverdorben, Martin
    BIOMARKERS IN MEDICINE, 2009, 3 (04) : 411 - 428
  • [7] Residual atherosclerotic cardiovascular disease risk in statin-treated adults: The Multi-Ethnic Study of Atherosclerosis
    Wong, Nathan D.
    Zhao, Yanglu
    Quek, Ruben G. W.
    Blumenthal, Roger S.
    Budoff, Matthew J.
    Cushman, Mary
    Garg, Parveen
    Sandfort, Veit
    Tsai, Michael
    Lopez, J. Antonio G.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2017, 11 (05) : 1223 - 1233
  • [8] Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risks
    Kao, Yu-Cheng
    Chen, Tien-Hsing
    Liu, Chi-Hung
    Hwang, Jawl-Shan
    Hsiao, Ching-Chung
    Lin, Yu-Sheng
    Mao, Chun-Tai
    Hung, Ming-Jui
    Li, Yan-Rong
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [9] Guidelines for Management of Hyperlipidemia: Implications for Treatment of Patients with Stroke Secondary to Atherosclerotic Disease
    Dandapat, Sudeepta
    Robinson, Jennifer G.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2016, 16 (03) : 1 - 9
  • [10] Underprescribing of statin therapy in people with HIV at risk for atherosclerotic cardiovascular disease
    Aragon, Kelsea Gallegos
    Ray, Gretchen
    Conklin, Jessica
    Stever, Erin
    Marquez, Carlos
    Magallanes, Adan
    Anderson, Joe
    Jakeman, Bernadette
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (22) : 2026 - 2031